Eupatilin Inhibits Gastric Cancer Cell Growth by Blocking STAT3-Mediated VEGF Expression

다국어 초록 (Multilingual Abstract)

Purpose: Eupatilin is an antioxidative flavone and a phytopharmaceutical derived from Artemisia asiatica. It has been reported to possess anti-tumor activity in some types of cancer including gastric cancer. Eupatilin may modulate the angiogenesis pathway which is part of anti-inflammatory effect demonstrated in gastric mucosal injury models. Here we investigated the anti-tumor effects of eupatilin on gastric cancer cells and elucidated the potential underlying mechanism whereby eupatilin suppresses angiogenesis and tumor growth. Materials and Methods: The impact of eupatilin on the expression of angiogenesis pathway proteins was assessed using western blots in MKN45 cells. Using a chromatin immunoprecipitation assay, we tested whether eupatilin affects the recruitment of signal transducer and activator of transcription 3 (STAT3), aryl hydrocarbon receptor nuclear translocator (ARNT) and hypoxia-inducible factor-1Ձ (HIF-1Ձ) to the human VEGF promoter. To investigate the effect of eupatilin on vasculogenesis, tube formation assays were conducted using human umbilical vein endothelial cells (HUVECs). The effect of eupatilin on tumor suppression in mouse xenografts was assessed. Results: Eupatilin significantly reduced VEGF, ARNT and STAT3 expression prominently under hypoxic conditions. The recruitment of STAT3, ARNT and HIF-1Ձ to the VEGF promoter was inhibited by eupatilin treatment. HUVECs produced much foreshortened and severely broken tubes with eupatilin treatment. In addition, eupatilin effectively reduced tumor growth in a mouse xenograft model. Conclusions: Our results indicate that eupatilin inhibits angiogenesis in gastric cancer cells by blocking STAT3 and VEGF expression, suggesting its therapeutic potential in the treatment of gastric cancer.

참고문헌 (Reference)

1 Shweiki D, "Vascular endothelial growth factor induced by hypoxia may mediate hypoxiainitiated angiogenesis" 359 : 843-845, 1992

2 Grunstein J, "Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function" 59 : 1592-1598, 1999

3 Folkman J, "Tumor angiogenesis: therapeutic implications" 285 : 1182-1186, 1971

4 Xu Q, "Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways" 24 : 5552-5560, 2005

5 Bowman T, "STATs in oncogenesis" 19 : 2474-2488, 2000

6 Darnell JE Jr, "STATs and gene regulation" 277 : 1630-1635, 1997

7 Frank DA, "STAT3 as a central mediator of neoplastic cellular transformation" 251 : 199-210, 2007

8 Catlett-Falcone R, "STAT proteins as novel targets for cancer therapy. Signal transducer an activator of transcription" 11 : 490-496, 1999

9 Semenza GL, "Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1" 15 : 551-578, 1999

10 Feldser D, "Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2" 59 : 3915-3918, 1999

11 Oh TY, "Protective effect of DA-9601, an extract of Artemisiae Herba, against naproxen-induced gastric damage in arthritic rats" 20 : 414-419, 1997

12 Jiang BH, "Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells" 1749-1753, 2000

13 Oh TY, "Oxidative stress is more important than acid in the pathogenesis of refl ux oesophagitis in rats" 49 : 364-371, 2001

14 Oh TY, "Oxidative damages are critical in pathogenesis of refl ux esophagitis: implication of antioxidants in its treatment" 30 : 905-915, 2001

15 Rak J, "Oncogenes and angiogenesis: signaling three-dimensional tumor growth" 24-33, 2000

16 Sinibaldi D, "Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fi broblasts: role of activated STAT3 signaling" 19 : 5419-5427, 2000

17 Semenza GL, "Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology" 7 : 345-350, 2001

18 Wang GL, "Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension" 5510-5514, 1995

19 Gray MJ, "HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas" 24 : 3110-3120, 2005

20 Millauer B, "Gliobalstoma growth inhibited in vivo by a dominant-negative Flk-1 mutant" 367 : 576-579, 1994

21 Ellis LM, "Down-regulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specifi c for c-src" 273 : 1052-1057, 1998

22 Wiener JR, "Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model" 5 : 2164-2170, 1999

23 Elson DA, "Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcino genesis and wound healing" 60 : 6189-6195, 2000

24 Niu G, "Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis" 21 : 2000-2008, 2002

25 Folkman J, "Clinical applications of research on angiogenesis" 333 : 1757-1763, 1995